Commonly Prescribed Acid Reflux Medication Not Helpful for Children With Asthma

Published Online: Friday, July 20, 2012
Follow Pharmacy_Times:
Acid reflux is common among children with asthma, and in recent years there has been a dramatic increase in prescriptions of proton pump inhibitors (PPIs) for children with asthma. This episode of the JAMA Report discusses a controlled study in which pediatric asthma patients without acid reflux symptoms were given either placebo or a PPI in addition to corticosteroids. The study found that PPI treatment did not improve asthma symptoms and may come with risks, including increased chance of infection.
 
To read our article on the study, click here.

Related Articles
Clinical guidelines and government agencies are increasingly encouraging clinicians to consider patients’ treatment preferences when chronic disease is present.
AstraZeneca and Abbott are teaming up to develop companion diagnostic blood tests that will identify patients with severe asthma who would benefit most from biological tralokinumab therapy.
Asthma controller medications are underused in neighborhoods with high rates of asthma-related emergency room use and hospitalization, but pharmacists are in a prime position to correct it.
The FDA today expanded the indication of fluticasone furoate/vilanterol (Breo Ellipta) for the treatment of asthma.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$